Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Inc'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Clearmind Medicine Inc'in toplam varlıkları $0 olup, net 损失 $0'dir.
CMND'ün temel finansal oranları nelerdir?
Clearmind Medicine Inc'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
Clearmind Medicine Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Clearmind Medicine Inc 最大收入来源是 Insurance Agency and Insurance Technology,在最近的收益报告中收入为 40,014,380。就地区而言, China 是 Clearmind Medicine Inc 的主要市场,收入为 40,014,380。
Clearmind Medicine Inc kârlı mı?
不, son mali tablolara göre Clearmind Medicine Inc'in net 损失 $0'dir.
Clearmind Medicine Inc'in herhangi bir yükümlülüğü var mı?
不, Clearmind Medicine Inc'in yükümlülüğü 0'dir.
Clearmind Medicine Inc'in tedavüldeki hisse sayısı kaçtır?
Clearmind Medicine Inc'in toplam tedavüldeki hisse sayısı 0'dir.